tiprankstipranks
Trending News
More News >
Sihuan Pharmaceutical Holdings Group Ltd. (HK:0460)
:0460
Hong Kong Market

Sihuan Pharmaceutical Holdings Group (0460) Income Statement

Compare
1 Followers

Sihuan Pharmaceutical Holdings Group Income Statement

Last quarter (Q2 2025), Sihuan Pharmaceutical Holdings Group's total revenue was ¥1.15B, an increase of 8.57% from the same quarter last year. In Q2, Sihuan Pharmaceutical Holdings Group's net income was ¥102.60M. See Sihuan Pharmaceutical Holdings Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.90B¥ 1.86B¥ 2.18B¥ 3.04B¥ 2.46B
Gross Profit
¥ 1.24B¥ 1.30B¥ 1.49B¥ 2.43B¥ 1.91B
Operating Expenses
¥ 1.38B¥ 1.13B¥ 3.32B¥ 1.66B¥ 1.13B
Depreciation and Amortization
¥ 180.75M¥ 226.23M¥ 369.81M¥ 255.49M¥ 228.25M
EBITDA
¥ -208.66M¥ 334.31M¥ -1.54B¥ 931.69M¥ 714.06M
Operating Income
¥ -138.13M¥ 161.70M¥ -1.83B¥ 771.95M¥ 787.13M
Other Income/Expenses
¥ -290.16M¥ -322.96M¥ -292.05M¥ -275.93M¥ -21.28M
Pretax Income
¥ -428.29M¥ -161.26M¥ -2.12B¥ 496.01M¥ 765.84M
Net Income
¥ -216.66M¥ -54.02M¥ -1.91B¥ 416.51M¥ 473.38M
Per Share Metrics
Basic EPS
¥ -0.02¥ -0.01¥ -0.21¥ 0.04¥ 0.05
Diluted EPS
¥ -0.02¥ -0.01¥ -0.21¥ 0.04¥ 0.05
Weighted Average Shares Outstanding
9.27B 9.30B 9.33B 9.43B 9.47B
Weighted Average Shares Outstanding (Diluted)
9.27B 9.30B 9.33B 9.48B 9.47B
Currency in CNY

Sihuan Pharmaceutical Holdings Group Earnings and Revenue History